A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis

Stopped early · Phase 4 · Has a placebo group

Conditions studied: Palmoplantar Psoriasis, Genital Psoriasis

In brief

The purpose of this study is to measure the safety and effectiveness of deucravatinib in participants with non-pustular palmoplantar psoriasis and genital psoriasis.

Key facts

Study ID

NCT06042920

Run by

Bristol-Myers Squibb

People needed

130

Starts

2023-10-09

Expected to finish

2025-04-25

Last updated by the study team

2026-04-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Local Institution - 0050 — Phoenix, Arizona, United States
• Local Institution - 0015 — Fountain Valley, California, United States
• Local Institution - 0009 — Los Angeles, California, United States
• Local Institution - 0004 — Santa Monica, California, United States
• Local Institution - 0057 — Skokie, Illinois, United States
• Local Institution - 0052 — Indianapolis, Indiana, United States
• Local Institution - 0053 — Plainfield, Indiana, United States
• Local Institution - 0029 — Rockville, Maryland, United States
• Local Institution - 0012 — Detroit, Michigan, United States
• Local Institution - 0005 — East Windsor, New Jersey, United States
• Local Institution - 0002 — New York, New York, United States
• Local Institution - 0008 — New York, New York, United States
• Local Institution - 0062 — New York, New York, United States
• Local Institution - 0001 — Winston-Salem, North Carolina, United States
• Local Institution - 0066 — Boardman, Ohio, United States
• Local Institution - 0055 — Mayfield Heights, Ohio, United States
• Local Institution - 0056 — Pittsburgh, Pennsylvania, United States
• Local Institution - 0010 — Houston, Texas, United States
• Local Institution - 0007 — Norfolk, Virginia, United States
• Local Institution - 0033 — Mill Creek, Washington, United States
• Local Institution - 0043 — Ciudad Autónoma Buenos Aires, B, Argentina
• Local Institution - 0037 — Ciudad Autónoma Buenos Aires, B, Argentina
• Local Institution - 0034 — Ciudad Autonoma Buenos Aires, C, Argentina
• Local Institution - 0042 — Rosario, S, Argentina
• Local Institution - 0058 — Newmarket, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.